purchase customization

1 Introduction to Research & Analysis Reports
1.1 Drugs for Short Bowel Syndrome Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Short Bowel Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Short Bowel Syndrome Overall Market Size
2.1 Global Drugs for Short Bowel Syndrome Market Size: 2021 VS 2028
2.2 Global Drugs for Short Bowel Syndrome Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Short Bowel Syndrome Players in Global Market
3.2 Top Global Drugs for Short Bowel Syndrome Companies Ranked by Revenue
3.3 Global Drugs for Short Bowel Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Short Bowel Syndrome Companies in Global Market, by Revenue in 2021
3.5 Global Companies Drugs for Short Bowel Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Short Bowel Syndrome Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Short Bowel Syndrome Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Short Bowel Syndrome Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Drugs for Short Bowel Syndrome Market Size Markets, 2021 & 2028
4.1.2 GLP-2
4.1.3 Growth Hormone
4.1.4 Glutamine
4.1.5 Other
4.2 By Type - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
4.2.1 By Type - Global Drugs for Short Bowel Syndrome Revenue, 2017-2022
4.2.2 By Type - Global Drugs for Short Bowel Syndrome Revenue, 2023-2028
4.2.3 By Type - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Short Bowel Syndrome Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
5.2.1 By Application - Global Drugs for Short Bowel Syndrome Revenue, 2017-2022
5.2.2 By Application - Global Drugs for Short Bowel Syndrome Revenue, 2023-2028
5.2.3 By Application - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Drugs for Short Bowel Syndrome Market Size, 2021 & 2028
6.2 By Region - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
6.2.1 By Region - Global Drugs for Short Bowel Syndrome Revenue, 2017-2022
6.2.2 By Region - Global Drugs for Short Bowel Syndrome Revenue, 2023-2028
6.2.3 By Region - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Drugs for Short Bowel Syndrome Revenue, 2017-2028
6.3.2 US Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.3.3 Canada Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.3.4 Mexico Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Drugs for Short Bowel Syndrome Revenue, 2017-2028
6.4.2 Germany Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.4.3 France Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.4.4 U.K. Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.4.5 Italy Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.4.6 Russia Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.4.7 Nordic Countries Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.4.8 Benelux Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Drugs for Short Bowel Syndrome Revenue, 2017-2028
6.5.2 China Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.5.3 Japan Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.5.4 South Korea Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.5.5 Southeast Asia Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.5.6 India Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Drugs for Short Bowel Syndrome Revenue, 2017-2028
6.6.2 Brazil Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.6.3 Argentina Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Short Bowel Syndrome Revenue, 2017-2028
6.7.2 Turkey Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.7.3 Israel Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.7.4 Saudi Arabia Drugs for Short Bowel Syndrome Market Size, 2017-2028
6.7.5 UAE Drugs for Short Bowel Syndrome Market Size, 2017-2028
7 Players Profiles
7.1 Ardelyx
7.1.1 Ardelyx Corporate Summary
7.1.2 Ardelyx Business Overview
7.1.3 Ardelyx Drugs for Short Bowel Syndrome Major Product Offerings
7.1.4 Ardelyx Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.1.5 Ardelyx Key News
7.2 Emmaus Life Sciences
7.2.1 Emmaus Life Sciences Corporate Summary
7.2.2 Emmaus Life Sciences Business Overview
7.2.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Major Product Offerings
7.2.4 Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.2.5 Emmaus Life Sciences Key News
7.3 GLyPharma Therapeutic
7.3.1 GLyPharma Therapeutic Corporate Summary
7.3.2 GLyPharma Therapeutic Business Overview
7.3.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Major Product Offerings
7.3.4 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.3.5 GLyPharma Therapeutic Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Drugs for Short Bowel Syndrome Major Product Offerings
7.4.4 Merck Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.4.5 Merck Key News
7.5 Naia Pharmaceuticals
7.5.1 Naia Pharmaceuticals Corporate Summary
7.5.2 Naia Pharmaceuticals Business Overview
7.5.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Major Product Offerings
7.5.4 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.5.5 Naia Pharmaceuticals Key News
7.6 Nutrinia
7.6.1 Nutrinia Corporate Summary
7.6.2 Nutrinia Business Overview
7.6.3 Nutrinia Drugs for Short Bowel Syndrome Major Product Offerings
7.6.4 Nutrinia Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.6.5 Nutrinia Key News
7.7 OxThera
7.7.1 OxThera Corporate Summary
7.7.2 OxThera Business Overview
7.7.3 OxThera Drugs for Short Bowel Syndrome Major Product Offerings
7.7.4 OxThera Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.7.5 OxThera Key News
7.8 Sancilio & Company
7.8.1 Sancilio & Company Corporate Summary
7.8.2 Sancilio & Company Business Overview
7.8.3 Sancilio & Company Drugs for Short Bowel Syndrome Major Product Offerings
7.8.4 Sancilio & Company Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.8.5 Sancilio & Company Key News
7.9 Takeda
7.9.1 Takeda Corporate Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Drugs for Short Bowel Syndrome Major Product Offerings
7.9.4 Takeda Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.9.5 Takeda Key News
7.10 Zealand Pharma
7.10.1 Zealand Pharma Corporate Summary
7.10.2 Zealand Pharma Business Overview
7.10.3 Zealand Pharma Drugs for Short Bowel Syndrome Major Product Offerings
7.10.4 Zealand Pharma Drugs for Short Bowel Syndrome Revenue in Global Market (2017-2022)
7.10.5 Zealand Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer